Crohn’s Disease (CD) Treatment Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Crohn’s Disease (CD) Treatment Market Be Worth By 2029?
The market size for the treatment of Crohn’s disease (cd) has seen consistent expansion in the last few years. An increase from $11.76 billion in 2024 to $12.32 billion in 2025 is projected, demonstrating a compound annual growth rate (CAGR) of 4.8%. The past growth of the market has been influenced by factors such as increased incidence of Crohn’s disease, heightened public knowledge of the condition, government efforts, and lifestyle changes.
In the coming years, a robust growth is anticipated for the Crohn’s Disease (CD) treatment market, with its size potentially reaching $15.01 billion by 2029, following a Compound Annual Growth Rate (CAGR) of 5.1%. The projected increase can be traced back to the escalating demand for combined therapies, rising acceptance of biologics, and the substantial investments poured into research and development for CD treatments. Upcoming trends within the forecast period include the development of biologic drugs, innovative product introductions, the utilization of advanced diagnostic tools, and the increasing acceptance of biosimilars.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp
What External And Internal Drivers Are Influencing The Crohn’s Disease (CD) Treatment Market?
The surge in instances of inflammatory bowel diseases is anticipated to bolster the progression of the treatment market for Crohn’s disease (CD). Inflammatory bowel disease (IBD), a collection of chronic inflammatory conditions mainly affecting the gastrointestinal (GI) tract, is managed by Crohn’s Disease (CD) treatment, providing relief from symptoms, minimising inflammation, inducing remission, and improving the overall life quality of those enduring chronic inflammatory bowel disease. For example, a prediction from the United States National Library of Medicine, an American medical library, in September 2023, stated that in Canada, the rate of inflammatory bowel diseases (IBD) was projected to be 30 per 100,000 person years in 2023, with prospective assessments indicating a consistent surge of nearly 0.58% annually. By 2023, it was expected that the prevalence of IBD in Canada would reach approximately 825 per 100,000, with future estimates predicting a potential rise to 1.1% of the population by 2035. Hence, this escalating occurrence of inflammatory bowel diseases is fuelling the growth of the market for Crohn’s disease (CD) treatment.
What Segmentation Insights Are Provided In The Crohn’s Disease (CD) Treatment Market Research?
The crohn’s disease (cd) treatmentmarket covered in this report is segmented –
1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
2) By Route of Administration: Oral; Injectable
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
Subsegments:
1) By Antibiotics: Metronidazole; Ciprofloxacin; Rifaximin
2) By Amino Salicylates: Mesalamine; Sulfasalazine
3) By Corticosteroids: Prednisone; Budesonide; Hydrocortisone
4) By Immunomodulators: Azathioprine; Mercaptopurine; Methotrexate
5) By Other Drug Types: Biologic Therapies; Janus Kinase Inhibitors; Small Molecules
Which Market Trends Are Expected To Define The Future Of The Crohn’s Disease (CD) Treatment Market?
Leading firms in the Crohn’s disease (CD) treatment market are embracing innovative technologies, such as IBDSENSE, to maintain their market standing. For example, The IRR Chemistry Hub, situated in Scotland, unveiled IBDSENSE in March 2023. This technology is designed to enhance the diagnosis and monitoring of inflammatory bowel disease using non-invasive techniques, including those for Crohn’s disease. The project involves the use of a fluorescence-based technique to analyze the enzyme activity of Granzyme B (GzmB) in patient biosamples. The intention of this technology is to elevate the patient experience and broaden treatment options.
Who Are The Leading Companies Driving The Crohn’s Disease (CD) Treatment Market?
Major companies operating in the crohn’s disease (cd) treatment market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Crohn’s Disease (CD) Treatment Market?
North America was the largest region in the Crohn’s disease (CD) treatment market in 2024. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12902&type=smp
Browse Through More Reports Similar to the Global Crohn’s Disease (CD) Treatment Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025
Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
